26 results on '"Mohajer J"'
Search Results
2. Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability
- Author
-
MS Radiotherapie, Cancer, Sritharan, K, Akhiat, A, Cahill, D, Choi, S, Choudhury, A, Chung, P, Diaz, J, Dysager, L, Hall, W, Huddart, R, Kerkmeijer, L G W, Lawton, C, Mohajer, J, Murray, J, Nyborg, C J, Pos, F J, Rigo, M, Schytte, T, Sidhom, M, Sohaib, A, Tan, A, van der Voort van Zyp, J, Vesprini, D, Zelefsky, M J, Tree, A C, MS Radiotherapie, Cancer, Sritharan, K, Akhiat, A, Cahill, D, Choi, S, Choudhury, A, Chung, P, Diaz, J, Dysager, L, Hall, W, Huddart, R, Kerkmeijer, L G W, Lawton, C, Mohajer, J, Murray, J, Nyborg, C J, Pos, F J, Rigo, M, Schytte, T, Sidhom, M, Sohaib, A, Tan, A, van der Voort van Zyp, J, Vesprini, D, Zelefsky, M J, and Tree, A C
- Published
- 2024
3. Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer
- Author
-
Hunt, A., Hanson, I., Dunlop, A., Barnes, H., Bower, L., Chick, J., Cruickshank, C., Hall, E., Herbert, T., Lawes, R., McQuaid, D., McNair, H., Mitchell, A., Mohajer, J., Morgan, T., Oelfke, U., Smith, G., Nill, S., Huddart, R., and Hafeez, S.
- Published
- 2020
- Full Text
- View/download PDF
4. Validating a Simple Urethra Surrogate Model to Facilitate Dosimetric Analysis to Predict Genitourinary Toxicity
- Author
-
Ratnakumaran, R., primary, Mohajer, J., additional, Lee, E., additional, Withey, S., additional, Brand, D.H., additional, Loblaw, D.A., additional, Tolan, S., additional, van As, N., additional, and Tree, A., additional
- Published
- 2023
- Full Text
- View/download PDF
5. Is the Motion Causing a Commotion? Two-Fraction Prostate SBRT on the MR-Linac
- Author
-
Westley, R., primary, Dunlop, A., additional, Alexander, S., additional, Mitchell, A., additional, Diamantopoulos, S., additional, Chick, J., additional, Hall, E., additional, Mohajer, J., additional, and Tree, A., additional
- Published
- 2023
- Full Text
- View/download PDF
6. PO-1501 HERMES: Are we delivering?
- Author
-
Westley, R., primary, Dunlop, A., additional, Mitchell, A., additional, Diamantopoulos, S., additional, Alexander, S., additional, Herbert, T., additional, Mohajer, J., additional, Oelfke, U., additional, and Tree, A., additional
- Published
- 2023
- Full Text
- View/download PDF
7. PO-1662 Two-fraction prostate radiotherapy using high field MR-linac: technique and initial experience
- Author
-
Mitchell, R.A., primary, Diamantopoulos, S., additional, Dunlop, A., additional, Alexander, S., additional, Goodwin, E., additional, Herbert, T., additional, Jones, S., additional, Mohajer, J., additional, Nill, S., additional, Smith, G.A., additional, Westley, R., additional, Oelfke, U., additional, and Tree, A., additional
- Published
- 2022
- Full Text
- View/download PDF
8. PO-1314 Magnetic Resonance guided radiotherapy (MRgRT) in Gynaecological cancer: targets and gains
- Author
-
Ingle, M., primary, White, I., additional, Chick, J., additional, Mohajer, J., additional, Dunlop, A., additional, McNair, H., additional, Herbert, T., additional, Barnes, H., additional, Smith, G., additional, and Lalondrelle, S., additional
- Published
- 2021
- Full Text
- View/download PDF
9. PO-1828: Alignment of prostate cancer patients for radiotherapy on the MR-linac
- Author
-
Barnes, H., primary, Mohajer, J., additional, Dunlop, A., additional, Adair Smith, G., additional, Herbert, T., additional, Lawes, R., additional, Tree, A., additional, and McNair, H., additional
- Published
- 2020
- Full Text
- View/download PDF
10. PO-1626: Cervical cancer IGRT: A comparison of offline, online and MRI guided adaptive planning strategies
- Author
-
White, I., primary, McQuaid, D., additional, Goodwin, E., additional, Mohajer, J., additional, and Lalondrelle, S., additional
- Published
- 2020
- Full Text
- View/download PDF
11. OC-0469: MR-guided online adaptive radiotherapy for muscle invasive bladder cancer: First UK experience
- Author
-
Hunt, A., primary, Hanson, I., additional, Dunlop, A., additional, Bower, L., additional, Barnes, H., additional, Chick, J., additional, Herbert, T., additional, Lawes, R., additional, McNair, H., additional, Mitchell, A., additional, Mohajer, J., additional, Morgan, T., additional, Smith, G., additional, Nill, S., additional, Oelfke, U., additional, Huddart, R., additional, and Hafeez, S., additional
- Published
- 2020
- Full Text
- View/download PDF
12. OC-0465: Evaluation of the use of electron density overrides in MR-Linac breast treatment planning
- Author
-
Mohajer, J., primary, Mitchell, A., additional, Dunlop, A., additional, Nill, S., additional, and Oelfke, U., additional
- Published
- 2020
- Full Text
- View/download PDF
13. PH-0528: Feasibility of MR-guided stereotactic body radiotherapy in 5, 2 or 1 fractions for prostate cancer
- Author
-
Mohajer, J., primary, Dunlop, A., additional, Mitchell, A., additional, Nill, S., additional, Oelfke, U., additional, and Tree, A., additional
- Published
- 2020
- Full Text
- View/download PDF
14. PO-1437: Treatment plan robustness analysis for high field MR-linac partial breast plans
- Author
-
Mitchell, R.A., primary, Dunlop, A., additional, Chick, J., additional, Mohajer, J., additional, Goodwin, E., additional, Nill, S., additional, Lawes, R., additional, Herbert, T., additional, Kirby, A., additional, and Oelfke, U., additional
- Published
- 2020
- Full Text
- View/download PDF
15. EP-2014 Decision Support System for Checking Online Adaptive Treatments on the Elekta Unity
- Author
-
McQuaid, D., primary, Niliwar, R., additional, Mohajer, J., additional, Goodwin, E., additional, Nill, S., additional, and Oelfke, U., additional
- Published
- 2019
- Full Text
- View/download PDF
16. Implementing Plan of the Day for Cervical Cancer: A Comparison of Target Volume Generation Methods.
- Author
-
Wang L, Mohajer J, McNair H, Harris E, and Lalondrelle S
- Abstract
Purpose: Owing to substantial interfraction motion in cervical cancer, plan-of-the-day (PotD) adaptive radiation therapy may be of benefit to patients. Implementation is limited by uncertainty over how to generate the planning target volumes (PTVs). We compared published methods on our own patients., Methods and Materials: Forty patients each had 3 planning scans with variable bladder filling and daily cone beam computed tomographies (cone beam CTs) during radiation therapy; 5 to 11 cone beam CTs were selected to represent interfraction motion. Clinical target volumes (CTVs) and organs at risk were contoured following EMBRACE-II guidelines. A literature search identified 30 adaptive and nonadaptive solutions to PTV generation, which we applied to our patients. PTV sizes and mean coverage of the daily CTV were determined. For 11 patients, the clinically implemented, subjectively edited plan library was also investigated., Results: Eleven studies assessed 15 PotD strategies against nonadaptive comparators on a median of 14 patients (range, 9-23). Some PotD approaches applied margin recipes to the CTV on each planning scan, some modeled the CTV against bladder volume, and others applied incremental isotropic margins to the CTV with a single planning scan. Generally, coverage improved as PTV size increased. The fixed isotropic margin required to provide 100% coverage of all patients was 44 mm, with a mean PTV size of 3316 cm
3 . The PotD strategy with the best coverage was a 2-plan library formed by modeling the CTV against bladder volume with extrapolation; it provided 98% mean coverage with 1419-cm3 mean PTV size. A 3-plan library consisting of the CTV on each planning scan with 10-mm margin provided 96% mean coverage with 1346-cm3 mean PTV size. The clinically implemented solution that employed subjective extrapolation had mean 100% coverage and 1282-cm3 PTV size on the 11-patient subset. Coverage provided by the best nonadaptive strategies was not statistically superior to the best PotD strategy ( P = .13), but PTVs were larger ( P = .02)., Conclusions: We identified a modeled 2-plan method and a simple 3-plan method, both of which provided excellent coverage with small PTVs compared with nonadaptive strategies., Competing Interests: Lei Wang reports financial support was provided by Elekta and by Biomedical Research Council, ICR. Jonathan Mohajer reports funding grants from the Cancer Research UK. Helen McNair reports funding grants from National Institute for Health Research and Health Education England. Emma Harris reports funding grants from Elekta and Cancer Research UK. Susan Lalondrelle reports funding grants and speaking and lecture fees from Elekta., (© 2024 The Authors.)- Published
- 2024
- Full Text
- View/download PDF
17. Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity.
- Author
-
Ratnakumaran R, Mohajer J, Withey SJ, H Brand D, Lee E, Loblaw A, Tolan S, van As N, and Tree AC
- Abstract
Purpose: The urethra is a critical structure in prostate radiotherapy planning; however, it is impossible to visualise on CT. We developed a surrogate urethra model (SUM) for CT-only planning workflow and tested its geometric and dosimetric performance against the MRI-delineated urethra (MDU)., Methods: The SUM was compared against 34 different MDUs (within the treatment PTV) in patients treated with 36.25Gy (PTV)/40Gy (CTV) in 5 fractions as part of the PACE-B trial. To assess the surrogate's geometric performance, the Dice similarity coefficient (DSC), Hausdorff distance (HD), mean distance to agreement (MDTA) and the percentage of MDU outside the surrogate (UOS) were calculated. To evaluate the dosimetric performance, a paired t -test was used to calculate the mean of differences between the MDU and SUM for the D99, D98, D50, D2 and D1. The D(n) is the dose (Gy) to n% of the urethra., Results: The median results showed low agreement on DSC (0.32; IQR 0.21-0.41), but low distance to agreement, as would be expected for a small structure (HD 8.4mm (IQR 7.1-10.1mm), MDTA 2.4mm (IQR, 2.2mm-3.2mm)). The UOS was 30% (IQR, 18-54%), indicating nearly a third of the urethra lay outside of the surrogate. However, when comparing urethral dose between the MDU and SUM, the mean of differences for D99, D98 and D95 were 0.12Gy (p=0.57), 0.09Gy (p=0.61), and 0.11Gy (p=0.46) respectively. The mean of differences between the D50, D2 and D1 were 0.08Gy (p=0.04), 0.09Gy (p=0.02) and 0.1Gy (p=0.01) respectively, indicating good dosimetric agreement between MDU and SUM., Conclusion: While there were geometric differences between the MDU and SUM, there was no clinically significant difference between urethral dose-volume parameters. This surrogate model could be validated in a larger cohort and then used to estimate the urethral dose on CT planning scans in those without an MRI planning scan or urinary catheter., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ragu Ratnakumaran reports speaker fees from Accuray. Alison Tree reports research support from Elekta, Varian and Accuray, and honoraria/travel assistance from Elekta, Accuray and Janssen., (© 2024 The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
18. Measurement and Incorporation of Laryngeal Motion Using cine-MRI on an MR-Linear Accelerator to Generate Radiation Therapy Plans for Early-stage Squamous Cell Cancers of the Glottis.
- Author
-
Gupta A, McQuaid D, Dunlop A, Barnes H, Mohajer J, Smith G, Nartey J, Morrison K, Herbert T, Alexander S, McNair H, Newbold K, Nutting C, Bhide S, Harrington KJ, and Wong KH
- Abstract
Purpose: Swallow-related motion of the larynx is most significant in the cranio-caudal directions and of` short duration. Conventional target definition for radical radiation therapy includes coverage of the whole larynx. This study longitudinally examined respiration- and swallow-related laryngeal motions using cine-magnetic resonance imaging. We further analyzed the dosimetry to organs at risk by comparing 3D-conformal radiation therapy (3D-CRT), volumetric modulated arc therapy (VMAT), and intensity modulated radiation therapy (IMRT) techniques., Methods: Fifteen patients with T1-2 N0 glottic squamous cell carcinomas were prospectively recruited for up to 3 cine-MRI scans on the Elekta Unity MR-Linear accelerator, at the beginning, middle, and end of a course of radical radiation therapy. Swallow frequency and motion of the hyoid bone, cricoid and thyroid cartilages, and vocal cords were recorded during swallow and rest. Adapted treatment volumes consisted of gross tumor volume + 0.5-1 cm to a clinical target volume with an additional internal target volume (ITV) for personalized resting-motion. Swallow-related motion was deemed infrequent and was not accounted for in the ITV. We compared radiation therapy plans for 3D-CRT (whole larynx), VMAT (whole larynx), and VMAT and IMRT (ITV for resting motion)., Results: Resting- and swallow-related motions were most prominent in the cranio-caudal plane. There were no significant changes in the magnitude of motion over the course of radiation therapy. There was a trend of a progressive reduction in the frequency of swallow. Treatment of partial larynx volumes with intensity modulated methods significantly reduced the dose to carotid arteries, compared with treatment of whole larynx volumes. Robustness analysis demonstrated that when accounting for intrafraction swallow, the total dose delivered to the ITV/planning target volume was maintained at above 95%., Conclusions: Swallow-related motions are infrequent and accounting for resting motion in an ITV is sufficient. VMAT/IMRT techniques that treat more conformal targets can significantly spare critical organs at risk such as the carotid arteries and thyroid gland, potentially reducing the risk of carotid artery stenosis-related complications and other long-term complications., Competing Interests: There are no disclosures to declare., (Crown Copyright © 2024 Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.)
- Published
- 2024
- Full Text
- View/download PDF
19. Development of Prostate Bed Delineation Consensus Guidelines for Magnetic Resonance Image-Guided Radiotherapy and Assessment of Its Effect on Interobserver Variability.
- Author
-
Sritharan K, Akhiat H, Cahill D, Choi S, Choudhury A, Chung P, Diaz J, Dysager L, Hall W, Huddart R, Kerkmeijer LGW, Lawton C, Mohajer J, Murray J, Nyborg CJ, Pos FJ, Rigo M, Schytte T, Sidhom M, Sohaib A, Tan A, van der Voort van Zyp J, Vesprini D, Zelefsky MJ, and Tree AC
- Subjects
- Male, Humans, Prostate diagnostic imaging, Observer Variation, Radiotherapy Planning, Computer-Assisted methods, Magnetic Resonance Imaging methods, Magnetic Resonance Spectroscopy, Radiotherapy, Image-Guided methods
- Abstract
Purpose: The use of magnetic resonance imaging (MRI) in radiotherapy planning is becoming more widespread, particularly with the emergence of MRI-guided radiotherapy systems. Existing guidelines for defining the prostate bed clinical target volume (CTV) show considerable heterogeneity. This study aimed to establish baseline interobserver variability (IOV) for prostate bed CTV contouring on MRI, develop international consensus guidelines, and evaluate its effect on IOV., Methods and Materials: Participants delineated the CTV on 3 MRI scans, obtained from the Elekta Unity MR-Linac, as per their normal practice. Radiation oncologist contours were visually examined for discrepancies, and interobserver comparisons were evaluated against simultaneous truth and performance level estimation (STAPLE) contours using overlap metrics (Dice similarity coefficient and Cohen's kappa), distance metrics (mean distance to agreement and Hausdorff distance), and volume measurements. A literature review of postradical prostatectomy local recurrence patterns was performed and presented alongside IOV results to the participants. Consensus guidelines were collectively constructed, and IOV assessment was repeated using these guidelines., Results: Sixteen radiation oncologists' contours were included in the final analysis. Visual evaluation demonstrated significant differences in the superior, inferior, and anterior borders. Baseline IOV assessment indicated moderate agreement for the overlap metrics while volume and distance metrics demonstrated greater variability. Consensus for optimal prostate bed CTV boundaries was established during a virtual meeting. After guideline development, a decrease in IOV was observed. The maximum volume ratio decreased from 4.7 to 3.1 and volume coefficient of variation reduced from 40% to 34%. The mean Dice similarity coefficient rose from 0.72 to 0.75 and the mean distance to agreement decreased from 3.63 to 2.95 mm., Conclusions: Interobserver variability in prostate bed contouring exists among international genitourinary experts, although this is lower than previously reported. Consensus guidelines for MRI-based prostate bed contouring have been developed, and this has resulted in an improvement in contouring concordance. However, IOV persists and strategies such as an education program, development of a contouring atlas, and further refinement of the guidelines may lead to additional improvements., (Copyright © 2023. Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
20. Evaluation of therapeutic radiographer contouring for magnetic resonance image guided online adaptive prostate radiotherapy.
- Author
-
Adair Smith G, Dunlop A, Alexander SE, Barnes H, Casey F, Chick J, Gunapala R, Herbert T, Lawes R, Mason SA, Mitchell A, Mohajer J, Murray J, Nill S, Patel P, Pathmanathan A, Sritharan K, Sundahl N, Tree AC, Westley R, Williams B, and McNair HA
- Subjects
- Male, Humans, Prostate, Seminal Vesicles, Pelvis, Magnetic Resonance Imaging methods, Radiotherapy Planning, Computer-Assisted methods, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms radiotherapy, Radiotherapy, Image-Guided methods
- Abstract
Background and Purpose: The implementation of MRI-guided online adaptive radiotherapy has facilitated the extension of therapeutic radiographers' roles to include contouring, thus releasing the clinician from attending daily treatment. Following undergoing a specifically designed training programme, an online interobserver variability study was performed., Materials and Methods: 117 images from six patients treated on a MR Linac were contoured online by either radiographer or clinician and the same images contoured offline by the alternate profession. Dice similarity coefficient (DSC), mean distance to agreement (MDA), Hausdorff distance (HD) and volume metrics were used to analyse contours. Additionally, the online radiographer contours and optimised plans (n = 59) were analysed using the offline clinician defined contours. After clinical implementation of radiographer contouring, target volume comparison and dose analysis was performed on 20 contours from five patients., Results: Comparison of the radiographers' and clinicians' contours resulted in a median (range) DSC of 0.92 (0.86 - 0.99), median (range) MDA of 0.98 mm (0.2-1.7) and median (range) HD of 6.3 mm (2.5-11.5) for all 117 fractions. There was no significant difference in volume size between the two groups. Of the 59 plans created with radiographer online contours and overlaid with clinicians' offline contours, 39 met mandatory dose constraints and 12 were acceptable because 95 % of the high dose PTV was covered by 95 % dose, or the high dose PTV was within 3 % of online plan. A clinician blindly reviewed the eight remaining fractions and, using trial quality assurance metrics, deemed all to be acceptable. Following clinical implementation of radiographer contouring, the median (range) DSC of CTV was 0.93 (0.88-1.0), median (range) MDA was 0.8 mm (0.04-1.18) and HD was 5.15 mm (2.09-8.54) respectively. Of the 20 plans created using radiographer online contours overlaid with clinicians' offline contours, 18 met the dosimetric success criteria, the remaining 2 were deemed acceptable by a clinician., Conclusion: Radiographer and clinician prostate and seminal vesicle contours on MRI for an online adaptive workflow are comparable and produce clinically acceptable plans. Radiographer contouring for prostate treatment on a MR-linac can be effectively introduced with appropriate training and evaluation. A DSC threshold for target structures could be implemented to streamline future training., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr Helen A McNair reports financial support was provided by National Institute for Health Research and Health Education England. Alison Tree, Angela Pathmanathan, Rosalyne Westley reports a relationship with Elekta Ltd. Alison Tree reports a relationship with Accuray Inc. Alison Tree reports a relationship with Varian Medical Systems Inc. Alison Tree, Sophie Alexander reports a relationship with Cancer Research UK that. Research at The Institute of Cancer Research is also supported by Cancer Research UK under Programme C33589/A28284 and C7224/A28724.., (Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
21. Interobserver variation of clinical oncologists compared to therapeutic radiographers (RTT) prostate contours on T2 weighted MRI.
- Author
-
Adair Smith G, Dunlop A, Alexander SE, Barnes H, Casey F, Chick J, Gunapala R, Herbert T, Lawes R, Mason SA, Mitchell A, Mohajer J, Murray J, Nill S, Patel P, Pathmanathan A, Sritharan K, Sundahl N, Westley R, Tree AC, and McNair HA
- Abstract
The implementation of MRI-guided online adaptive radiotherapy has enabled extension of therapeutic radiographers' roles to include contouring. An offline interobserver variability study compared five radiographers' and five clinicians' contours on 10 MRIs acquired on a MR-Linac from 10 patients. All contours were compared to a "gold standard" created from an average of clinicians' contours. The median (range) DSC of radiographers' and clinicians' contours compared to the "gold standard" was 0.91 (0.86-0.96), and 0.93 (0.88-0.97) respectively illustrating non-inferiority of the radiographers' contours to the clinicians. There was no significant difference in HD, MDA or volume size between the groups., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr Helen A McNair reports financial support was provided by National Institute for Health Research and Health Education England. Alison Tree, Angela Pathmanathan, Rosalyne Westley reports a relationship with Elekta Ltd. Alison Tree reports a relationship with Accuray Inc. Alison Tree reports a relationship with Varian Medical Systems Inc. Alison Tree, Sophie Alexander reports a relationship with Cancer Research UK that. Research at The Institute of Cancer Research is also supported by Cancer Research UK under Programme C33589/A28284 and C7224/A28724., (© 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
22. Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?
- Author
-
Sritharan K, Dunlop A, Mohajer J, Adair-Smith G, Barnes H, Brand D, Greenlay E, Hijab A, Oelfke U, Pathmanathan A, Mitchell A, Murray J, Nill S, Parker C, Sundahl N, and Tree AC
- Abstract
Background: The prostate demonstrates inter- and intra- fractional changes and thus adaptive radiotherapy would be required to ensure optimal coverage. Daily adaptive radiotherapy for MRI-guided radiotherapy can be both time and resource intensive when structure delineation is completed manually. Contours can be auto-generated on the MR-Linac via a deformable image registration (DIR) based mapping process from the reference image. This study evaluates the performance of automatically generated target structure contours against manually delineated contours by radiation oncologists for prostate radiotherapy on the Elekta Unity MR-Linac., Methods: Plans were generated from prostate contours propagated by DIR and rigid image registration (RIR) for forty fractions from ten patients. A two-dose level SIB (simultaneous integrated boost) IMRT plan is used to treat localised prostate cancer; 6000 cGy to the prostate and 4860 cGy to the seminal vesicles. The dose coverage of the PTV 6000 and PTV 4860 created from the manually drawn target structures was evaluated with each plan. If the dose objectives were met, the plan was considered successful in covering the gold standard (clinician-delineated) volume., Results: The mandatory PTV 6000 dose objective (D98% > 5580 cGy) was met in 81 % of DIR plans and 45 % of RIR plans. The SV were mapped by DIR only and for all the plans, the PTV 4860 dose objective met the optimal target (D98% > 4617 cGy). The plans created by RIR led to under-coverage of the clinician-delineated prostate, predominantly at the apex or the bladder-prostate interface., Conclusion: Plans created from DIR propagation of prostate contours outperform those created from RIR propagation. In approximately 1 in 5 DIR plans, dosimetric coverage of the gold standard PTV was not clinically acceptable. Thus, at our institution, we use a combination of DIR propagation of contours alongside manual editing of contours where deemed necessary for online treatments., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
23. Bladder filling in patients undergoing prostate radiotherapy on a MR-linac: The dosimetric impact.
- Author
-
Smith GA, Dunlop A, Barnes H, Herbert T, Lawes R, Mohajer J, Tree AC, and McNair HA
- Abstract
The implementation of adaptive radiotherapy for prostate cancer compensates for inter-fraction motion, at the penalty of increased time in room. The subsequent increase in bladder filling may impact dosimetry, which we have investigated on ten patients treated on the MR-linac. Patients drank water before treatment, to achieve a bladder volume of 200-300 cm
3 . Bladder and bowel were re-outlined offline on 140 images and plans recalculated. All mandatory bladder dose constraints and 99.1% of bowel constraints were achieved at time of treatment, despite varying bladder volumes and varying adherence to original bladder filling guidance., Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: This report is independent research supported by the National Institute for Health Research and Health Education England (HEE/ NIHR ICA Programme Senior Clinical Lectureship, Dr Helen McNair, ICA-SCL-2018-04-ST2-002). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. We also acknowledge NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research. AT acknowledges support from The Rosetrees Trust. The Institute of Cancer Research is supported by Cancer Research UK Programme Grants (C33589/A19727, C33589/A19908 and C33589/A28284). ICR/RMH is a member of the Elekta MR Linac Research Consortium and receives institutional support from Elekta. Dr. Tree reports grants and other from Elekta, during the conduct of the study; grants from Accuray, grants from Varian, other from Genesis Healthcare, outside the submitted work., (© 2022 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology.)- Published
- 2022
- Full Text
- View/download PDF
24. Feasibility of MR-guided ultrahypofractionated radiotherapy in 5, 2 or 1 fractions for prostate cancer.
- Author
-
Mohajer J, Dunlop A, Mitchell A, Goodwin E, Nill S, Oelfke U, and Tree A
- Abstract
The drive towards hypofractionated prostate radiotherapy is motivated by a low alpha/beta ratio for prostate cancer (1 to 3 Gy) compared to surrounding organs at risk, implying an improved therapeutic ratio with increasing dose per fraction. Early evidence from studies of ultrahypofractionated (UHF) prostate HDR brachytherapy has shown good tolerability in terms of normal tissue toxicities and clinical outcomes similar to conventional fractionation schedules. MR-guided stereotactic body radiotherapy (SBRT) with online plan adaptation and real-time tumour imaging may enable UHF doses to be delivered to the prostate safely, without the invasiveness of brachytherapy. The feasibility of UHF prostate treatment planning for the Unity MR-Linac (MRL, Elekta AB, Stockholm) was investigated for target prescriptions and planning constraints derived from the HDR brachytherapy and SBRT literature. Monaco 5.40 (Elekta) was used to generate MRL step-and-shoot IMRT plans for three dose fractionation protocols (5, 2 and 1 fractions), for ten randomly selected previously treated prostate cancer patients. Of the ten plans per UHF scheme, all clinical goals were met in all cases for 5 fractions, and in six cases for both 2 and 1 fraction schemes. PTV D95% was compromised by up to 6.4% and 3.9% of the associated target dose for 2 and 1 fraction plans respectively. There were two cases of PTV D95% compromise greater than a 5% dose decrease for the 2 fraction plans. The study suggests feasibility of the UHF treatment planning approaches if combined with real-time motion mitigation strategies., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
25. Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac.
- Author
-
Dunlop A, Mitchell A, Tree A, Barnes H, Bower L, Chick J, Goodwin E, Herbert T, Lawes R, McNair H, McQuaid D, Mohajer J, Nilawar R, Pathmanathan A, Smith G, Hanson I, Nill S, and Oelfke U
- Abstract
Introduction: MR-guided adapted radiotherapy (MRgART) using a high field MR-linac has recently become available. We report the estimated delivered fractional dose of the first five prostate cancer patients treated at our centre using MRgART and compare this to C-Arm linac daily Image Guided Radiotherapy (IGRT)., Methods: Patients were treated using adapted treatment plans shaped to their daily anatomy. The treatments were recalculated on an MR image acquired immediately prior to treatment delivery in order to estimate the delivered fractional dose. C-arm linac non-adapted VMAT treatment plans were recalculated on the same MR images to estimate the fractional dose that would have been delivered using conventional radiotherapy techniques using a daily IGRT protocol., Results: 95% and 93% of mandatory target coverage objectives and organ at risk dose constraints were achieved by MRgART and C-arm linac delivered dose estimates, respectively. Both delivery techniques were estimated to have achieved 98% of mandatory Organ At Risk (OAR) dose constraints whereas for the target clinical goals, 86% and 80% were achieved by MRgART and C-arm linac delivered dose estimates., Conclusions: Prostate MRgART can be delivered using the a high field MR-linac. Radiotherapy performed on a C-arm linac offers a good solution for prostate cancer patients who present with favourable anatomy at the time of reference imaging and demonstrate stable anatomy throughout the course of their treatment. For patients with critical OARs abutting target volumes on their reference image we have demonstrated the potential for a target dose coverage improvement for MRgART compared to C-arm linac treatment., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
26. Laser-free pelvic alignment in an online adaptive radiotherapy environment.
- Author
-
Barnes H, Mohajer J, Dunlop A, Adair Smith G, Herbert T, Lawes R, Tree A, and McNair H
- Abstract
The MR-Linac (MRL) provides a novel treatment modality that enables online adaptive treatments, but also creates new challenges for patient positioning in a laser-free environment. The accuracy and duration of prostate patient set-up on the MRL using two different methods for patient alignment was determined to establish standard of practice on the MRL. Differences in set-up accuracy were significant in the longitudinal direction and are accounted for in online plan adaption. Both methods recorded similar set-up times. The vendor recommended alignment method involves less manipulation of the patient and will be adopted as the standard positioning method for prostate and other pelvic patients on the MRL in future., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.